Table 5.
Prevalences of HEV IgG observed in industrialized countries with assays other that Wantai HEV-IgG ELISA.
| Country | Population | Assay | Number of Samples | HEV IgG (%) | Reference |
|---|---|---|---|---|---|
| Belgium | P | Strip immunoassay | 100 | 14 | [92] |
| Germany | GP | Mikrogen | 4422 | 16.8 | [90] |
| Germany | GP | 7075 | 15.3 | [93] | |
| Greece | BD | Adaltis | 265 | 9.43 | [94] |
| Hungary | P | In-house assay | 246 | 10.5 | [95] |
| Ireland | BD | ND | 198 | 8 | [96] |
| Israel | BD | Diagnostic system | 729 | 10.6 | [97] |
| Italy | BD | In-house assay | 199 | 7 | [98] |
| Japan | BD | In-house assay | 12,600 | 3.4 | [99] |
| Japan | GP | In-house assay | 22,027 | 5.3 | [100] |
| Netherlands | GP | ND | 7072 | 1.9 | [91] |
| Poland | BD | Euroimmun | 105 | 3.8 | [101] |
| Portugal | BD | Abbott | 1473 | 2.5 | [102] |
| Spain | BD | 563 | 2.8 | [103] | |
| Spain | GP | ND | NA | 10 | [104] |
| Spain | GP | Bioprobes | 2305 | 2.17 | [105] |
| Switzerland | BD | MP Diagnostics | 550 | 4.9 | [106] |
| UK | BD | ND | 500 | 16 | [107] |
| UK | PCLD | ND | 126 | 13 | |
| UK | OP | ND | 336 | 25 | |
| USA | GP | Diagnostic system | 5966 | 10.2 | [108] |
| USA | GP | 7885 | 6 | ||
| USA | BD | MP Diagnostics | 4499 | 9.5 | [109] |
BD: blood donors; PS: Professional soldiers; P: Patients; GP: General population; H: Hunters; PFW: Pig farm workers or in contact with pigs during job; FW: Forest workers; CH: Children; V: Veterinarians; FaW: Farmworkers; PCLD: Patients with chronic liver disease; OP: Old people; ND: assay not determined. Lists of assays: Mikrogen: RecomLine Anti-HEV IgG; Adaltis: AIAgen HEV; Diagnostic system: Anti-HEV-IgG kit; Euroimmun: Anti IgG HEv ELISA; Bioprobes: HEV IgG Diagnostic; MP Diagnostic: HEV ELISA. Abbott: HEV EIA.